9 Meters Biopharma Inc Sustainability Reports

9 Meters Biopharma, Inc. was a clinical-stage biopharmaceutical company focused on developing treatments for rare and unmet needs in gastroenterology, such as short bowel syndrome and celiac disease. The company ceased operations and filed for Chapter 7 bankruptcy liquidation in July 2023.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 549300TNBRYXYEAI2956

FIGI: BBG00BDX4VW0

1 reports from 2021 to 2021

• 9 Meters Biopharma Inc 2021 Form 10-K